ERBB2 and gastric cancer: Another HER2-targeting peptide, [111In]DTPA-AHNP-PEG evaluated in HER2-expressing gastric cancer (GC) tumor (NCI-N87) bearing mice demonstrated tumor-to-blood ratio of 6:1 at 4 h which is higher than of currently reported radiopeptides at 3 h.